- GRTSQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Gritstone bio (GRTSQ) 10-K/A2018 FY Annual report (amended)
Filed: 19 Apr 19, 12:00am
Exhibit 31.3
Certification of President and Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Andrew Allen, M.D., Ph.D., President and Chief Executive Officer of Gritstone Oncology, Inc., certify that:
1. I have reviewed this Amendment No. 1 to the Annual Report on Form10-K/A of Gritstone Oncology, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: April 18, 2019 | By: | /s/ Andrew Allen | ||||
Andrew Allen, M.D., Ph.D. | ||||||
President and Chief Executive Officer (Principal Executive Officer) |